Aquestive Therapeutics Inc (AQST)
5.15
-0.37
(-6.70%)
USD |
NASDAQ |
Nov 04, 16:00
5.09
-0.06
(-1.17%)
Pre-Market: 08:50
Aquestive Therapeutics Total Assets (Quarterly): 117.60M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 117.60M |
March 31, 2024 | 129.52M |
December 31, 2023 | 57.42M |
September 30, 2023 | 59.45M |
June 30, 2023 | 56.99M |
March 31, 2023 | 61.28M |
December 31, 2022 | 57.07M |
September 30, 2022 | 51.84M |
June 30, 2022 | 56.31M |
March 31, 2022 | 56.53M |
December 31, 2021 | 61.99M |
September 30, 2021 | 65.29M |
June 30, 2021 | 66.88M |
March 31, 2021 | 61.92M |
Date | Value |
---|---|
December 31, 2020 | 62.88M |
September 30, 2020 | 50.42M |
June 30, 2020 | 63.55M |
March 31, 2020 | 64.49M |
December 31, 2019 | 78.48M |
September 30, 2019 | 48.82M |
June 30, 2019 | 50.41M |
March 31, 2019 | 67.98M |
December 31, 2018 | 86.85M |
September 30, 2018 | 90.01M |
June 30, 2018 | 39.84M |
March 31, 2018 | 46.08M |
December 31, 2017 | 43.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
50.42M
Minimum
Sep 2020
129.52M
Maximum
Mar 2024
67.36M
Average
61.92M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
ACADIA Pharmaceuticals Inc | 914.10M |
Rockwell Medical Inc | 53.03M |
Cormedix Inc | 77.59M |
Geovax Labs Inc | 4.095M |
Myomo Inc | 16.19M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 153.08M |
Shareholders Equity (Quarterly) | -35.48M |
Debt to Equity Ratio | -0.8464 |
Current Ratio | 7.486 |
Net Debt Paydown Yield | 1.04% |